162 related articles for article (PubMed ID: 37367853)
1. Coronary Artery Disease with Elevated Levels of HDL Cholesterol Is Associated with Distinct Lipid Signatures.
Xia W; Yu H; Wang G
Metabolites; 2023 May; 13(6):. PubMed ID: 37367853
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidome.
Hancock-Cerutti W; Lhomme M; Dauteuille C; Lecocq S; Chapman MJ; Rader DJ; Kontush A; Cuchel M
J Clin Lipidol; 2017; 11(5):1192-1200.e3. PubMed ID: 28826666
[TBL] [Abstract][Full Text] [Related]
3. Untargeted Lipidomics Reveals a Specific Enrichment in Plasmalogens in Epicardial Adipose Tissue and a Specific Signature in Coronary Artery Disease.
Barchuk M; Dutour A; Ancel P; Svilar L; Miksztowicz V; Lopez G; Rubio M; Schreier L; Nogueira JP; Valéro R; Béliard S; Martin JC; Berg G; Gaborit B
Arterioscler Thromb Vasc Biol; 2020 Apr; 40(4):986-1000. PubMed ID: 32102570
[TBL] [Abstract][Full Text] [Related]
4. A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome.
Di Giorgi N; Michelucci E; Smit JM; Scholte AJHA; El Mahdiui M; Knuuti J; Buechel RR; Teresinska A; Pizzi MN; Roque A; Poddighe R; Parodi O; Pelosi G; Caselli C; Neglia D; Rocchiccioli S
Atherosclerosis; 2021 Dec; 339():1-11. PubMed ID: 34801858
[TBL] [Abstract][Full Text] [Related]
5. Decreased phosphatidylcholine plasmalogens--A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction.
Sutter I; Klingenberg R; Othman A; Rohrer L; Landmesser U; Heg D; Rodondi N; Mach F; Windecker S; Matter CM; Lüscher TF; von Eckardstein A; Hornemann T
Atherosclerosis; 2016 Mar; 246():130-40. PubMed ID: 26773473
[TBL] [Abstract][Full Text] [Related]
6. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
[TBL] [Abstract][Full Text] [Related]
7. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
Smuts CM; Weich HF; Weight MJ; Faber M; Kruger M; Lombard CJ; Benadé AJ
Coron Artery Dis; 1994 Apr; 5(4):331-8. PubMed ID: 8044345
[TBL] [Abstract][Full Text] [Related]
8. High-density lipoprotein lipid peroxidation as a diagnostics biomarker in coronary artery disease.
Yazdandoust S; Parizadeh SMR; Ghayour-Mobarhan M; Yaghmaei P; Sahebkar AH
Biofactors; 2022 May; 48(3):634-642. PubMed ID: 35080064
[TBL] [Abstract][Full Text] [Related]
9. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
[TBL] [Abstract][Full Text] [Related]
10. HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.
Meikle PJ; Formosa MF; Mellett NA; Jayawardana KS; Giles C; Bertovic DA; Jennings GL; Childs W; Reddy M; Carey AL; Baradi A; Nanayakkara S; Wilson AM; Duffy SJ; Kingwell BA
J Am Heart Assoc; 2019 Jun; 8(11):e011792. PubMed ID: 31131674
[TBL] [Abstract][Full Text] [Related]
11. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
[TBL] [Abstract][Full Text] [Related]
12. High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.
Agarwala AP; Rodrigues A; Risman M; McCoy M; Trindade K; Qu L; Cuchel M; Billheimer J; Rader DJ
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1515-9. PubMed ID: 25838421
[TBL] [Abstract][Full Text] [Related]
13. Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: the Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan.
Chang PY; Lee CM; Hsu HC; Lin HJ; Chien KL; Chen MF; Chen CH; Lee YT; Yang CY
Lipids Health Dis; 2012 Nov; 11():162. PubMed ID: 23173569
[TBL] [Abstract][Full Text] [Related]
14. HDL in humans with cardiovascular disease exhibits a proteomic signature.
Vaisar T; Mayer P; Nilsson E; Zhao XQ; Knopp R; Prazen BJ
Clin Chim Acta; 2010 Jul; 411(13-14):972-9. PubMed ID: 20307520
[TBL] [Abstract][Full Text] [Related]
15. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.
Bakogianni MC; Kalofoutis CA; Skenderi KI; Kalofoutis AT
J Diabetes Complications; 2001; 15(5):265-9. PubMed ID: 11522502
[TBL] [Abstract][Full Text] [Related]
18. Effect of Novel Stratified Lipid Risk by "LDL-Window" and Flow-Mediated Dilation on the Prognosis of Coronary Artery Disease Using the FMD-J Study A Data.
Abe S; Haruyama Y; Kobashi G; Toyoda S; Inoue T; Tomiyama H; Ishizu T; Kohro T; Higashi Y; Takase B; Suzuki T; Ueda S; Yamazaki T; Furumoto T; Kario K; Koba S; Takemoto Y; Hano T; Sata M; Ishibashi Y; Node K; Maemura K; Ohya Y; Furukawa T; Ito H; Yamashina A
Circ J; 2022 Aug; 86(9):1444-1454. PubMed ID: 35871575
[TBL] [Abstract][Full Text] [Related]
19. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
20. [The lipid profile and coronary artery disease].
Ladeia AM; Guimarães AC; Lima JC
Arq Bras Cardiol; 1994 Aug; 63(2):101-6. PubMed ID: 7661704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
